Clinical Trial Update: An Artificial Intelligence Model for Aiding Claudin18.2 Expression Diagnosis in Gastric Adenocarcinoma

View source ↗

Summary

The study, sponsored by Nanfang Hospital and Southern Medical University, is evaluating an artificial intelligence model to aid Claudin18.2 expression diagnosis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Digestive Oncology | Status: ENROLLING_BY_INVITATION